These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 3882737)

  • 1. Bromocriptine as primary therapy for prolactin-secreting macroadenomas: results of a prospective multicenter study.
    Molitch ME; Elton RL; Blackwell RE; Caldwell B; Chang RJ; Jaffe R; Joplin G; Robbins RJ; Tyson J; Thorner MO
    J Clin Endocrinol Metab; 1985 Apr; 60(4):698-705. PubMed ID: 3882737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-lasting suppression of prolactin secretion and rapid shrinkage of prolactinomas after a long-acting, injectable form of bromocriptine.
    Montini M; Pagani G; Gianola D; Pagani MD; Salmoiraghi M; Ferrari L; Lancranjan I
    J Clin Endocrinol Metab; 1986 Jul; 63(1):266-8. PubMed ID: 3711262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of a long-acting injectable form of bromocriptine in patients with prolactin and growth hormone secreting macroadenomas.
    Tsagarakis S; Tsiganou E; Tzavara I; Nikolou H; Thalassinos N
    Clin Endocrinol (Oxf); 1995 Jun; 42(6):593-9. PubMed ID: 7634499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bromocriptine treatment of microprolactinomas: evidence of stable prolactin decrease after drug withdrawal.
    Moriondo P; Travaglini P; Nissim M; Conti A; Faglia G
    J Clin Endocrinol Metab; 1985 Apr; 60(4):764-72. PubMed ID: 3919052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid regression of pituitary prolactinomas during bromocriptine treatment.
    Thorner MO; Martin WH; Rogol AD; Morris JL; Perryman RL; Conway BP; Howards SS; Wolfman MG; MacLeod RM
    J Clin Endocrinol Metab; 1980 Sep; 51(3):438-45. PubMed ID: 6773972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and pathological effects of bromocriptine on prolactin-secreting and other pituitary tumors.
    Barrow DL; Tindall GT; Kovacs K; Thorner MO; Horvath E; Hoffman JC
    J Neurosurg; 1984 Jan; 60(1):1-7. PubMed ID: 6689702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of tamoxifen administration on prolactin release by invasive prolactin-secreting pituitary adenomas.
    Lamberts SW; Verleun T; Oosterom R
    Neuroendocrinology; 1982; 34(5):339-42. PubMed ID: 7078703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A long-acting repeatable form of bromocriptine as long-term treatment of prolactin-secreting macroadenomas: a multicenter study.
    Brue T; Lancranjan I; Louvet JP; Dewailly D; Roger P; Jaquet P
    Fertil Steril; 1992 Jan; 57(1):74-80. PubMed ID: 1730334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-acting injectable bromocriptine (Parlodel LAR) in the chronic treatment of prolactin-secreting macroadenomas.
    Lengyel AM; Mussio W; Imamura P; Vieira JG; Lancranjan I
    Fertil Steril; 1993 May; 59(5):980-7. PubMed ID: 8486199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testosterone-related exacerbation of a prolactin-producing macroadenoma: possible role for estrogen.
    Prior JC; Cox TA; Fairholm D; Kostashuk E; Nugent R
    J Clin Endocrinol Metab; 1987 Feb; 64(2):391-4. PubMed ID: 3793856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of pituitary macroadenomas secreting PRL, HGH or ACTH with long-acting bromocriptine.
    Halperin I; Rodriguez MD; Cardenal C; Casamitjana R; Martinez Osaba MJ; Lienas V; Vilardell E
    J Endocrinol Invest; 1987 Jun; 10(3):277-82. PubMed ID: 3040850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bromocriptine treatment of prolactin-secreting pituitary adenomas may restore pituitary function.
    Warfield A; Finkel DM; Schatz NJ; Savino PJ; Snyder PJ
    Ann Intern Med; 1984 Dec; 101(6):783-5. PubMed ID: 6497193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of bromocriptine in the treatment of macroprolactinomas.
    Essaïs O; Bouguerra R; Hamzaoui J; Marrakchi Z; Hadjri S; Chamakhi S; Zidi B; Ben Slama C
    Ann Endocrinol (Paris); 2002 Dec; 63(6 Pt 1):524-31. PubMed ID: 12527854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of prolactin-secreting macroadenomas with the once-weekly dopamine agonist cabergoline.
    Biller BM; Molitch ME; Vance ML; Cannistraro KB; Davis KR; Simons JA; Schoenfelder JR; Klibanski A
    J Clin Endocrinol Metab; 1996 Jun; 81(6):2338-43. PubMed ID: 8964874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of prolactin-secreting macroadenomas with parenteral, long-acting bromocriptine in 30 patients treated for up to 3 years.
    Haase R; Jaspers C; Schulte HM; Lancranja I; Pfingsten H; Orri-Fend M; Reinwein D; Benker G
    Clin Endocrinol (Oxf); 1993 Feb; 38(2):165-76. PubMed ID: 8435897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of bromocriptine treatment on the fibrous tissue content of prolactin-secreting and nonfunctioning macroadenomas of the pituitary gland.
    Esiri MM; Bevan JS; Burke CW; Adams CB
    J Clin Endocrinol Metab; 1986 Aug; 63(2):383-8. PubMed ID: 3722328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bromocriptine treatment of pituitary adenomas. Evaluation of withdrawal effect.
    Coculescu M; Simionescu N; Oprescu M; Alessandrescu D
    Endocrinologie; 1983; 21(3):157-68. PubMed ID: 6635518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bromocriptine treatment of hyperprolactinemia].
    Gauer J; Heberling HJ; Stubert B; Richardt W; Lohmann D
    Z Gesamte Inn Med; 1985 Jul; 40(13):393-6. PubMed ID: 4036221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolactin-secreting macroadenomas in adolescents. Response to bromocriptine therapy.
    Tyson D; Reggiardo D; Sklar C; David R
    Am J Dis Child; 1993 Oct; 147(10):1057-61. PubMed ID: 8213676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extrasellar prolactinomas: successful management of 24 patients using bromocriptine.
    Sieck JO; Niles NL; Jinkins JR; Al-Mefty O; el-Akkad S; Woodhouse N
    Horm Res; 1986; 23(3):167-76. PubMed ID: 3949288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.